40% of COVID-19 survivors have a new disability, study finds
In a new study from Monash University, researchers found six months after recovering from COVID-19 critical illness, one in five people had died, and almost 40% of survivors had a new disability.
They looked at COVID-19 critical illness across Australia between March 6 and October 4, 2020, measuring mortality, new disability and return to work in people who had been admitted to intensive care units.
At six months, 43 of the 212 (20.3%) eligible patients had died, and 42 of the 108 (38.9%) surviving patients who responded to the study reported a new disability.
The study found 71.3% of surviving patients reported persistent symptoms such as shortness of breath, loss of strength, fatigue, headaches and loss of sense of smell and taste after recovering from the critical illness.
There was also a big decrease in health-related quality of life across all domains, but particular participants reported new problems with mobility (33.9%), usual activities (43.2%) and pain (34.2%), as well as cognitive impairment (33.3%).
In addition, one fifth (20%) reporting anxiety (20.2%), depression (20%) and/or PTSD (18.4%). More than one in 10 survivors were unemployed due to poor health.
With a median age of 61, 58 percent of participants were male with comorbidity of diabetes or obesity. Fifty-seven percent received mechanical ventilation.
The team says because COVID-19 is a new disease, the impact on long-term outcomes in survivors is still emerging.
However, these findings suggest that patients should be screened at hospital discharge for new functional impairments, as the burden of new disability after critical illness with COVID-19 represents an urgent public health problem.
If you care about COVID, please read studies about this common drug may prevent deadly inflammation in COVID-19 and findings of many people show new symptoms months after COVID-19.
For more information about COVID and your health, please see recent studies about high vitamin D levels may prevent COVID-19 and results showing that these 3 common antiviral drugs may effectively fight COVID-19.
The study is published in Critical Care. One author of the study is Professor Carol Hodgson.
Copyright © 2021 Knowridge Science Report. All rights reserved.